Clinical Medicine Reviews in Therapeutics 2010:2
Review
Published on 14 Jun 2010
DOI: 10.4137/CMRT.S3273
Sign up for email alerts to receive notifications of new articles published in Clinical Medicine Reviews in Therapeutics
Chronic hepatitis B virus (HBV) infection is a major cause of liver-related morbidity and mortality worldwide and is endemic in many areas of Asia and Africa. Adequate treatment of hepatitis B with effective antiviral agents can improve disease burden. Entecavir is a potent, selective nucleoside analogue with activity against HBV. In recent years, studies have been done on the safety, efficacy, resistance profile and therapeutic use of entecavir. This review will discuss pharmacological and clinical aspects of oral entecavir for use in adults with chronic hepatitis B virus infection.
RIS citation (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)
BibTex citation (BIBDESK, LATEX)
Facebook Twitter
Pinterest